Physician
Premier Medicine PC
Premier Medicine PC was paid $10.51M by Medicaid between Jan 2018 and Dec 2024, across 118 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 54% of everything it billed.
33Billing provider infoPREMIER MEDICINE PC
LIVONIA, MI 48152
LIVONIA, MI 48152
33aNPI1376623736assigned 10/17/2006
33bProvider typeFamily Medicine Physician
28Total paid$10.51M
24GClaims317,366
24DCodes billed118
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Michigan
Rank by total paid#13 of 826
Median peer was paid$98K
This provider vs. median108×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,960 | $834K | |
| 2019 | 27,397 | $1.05M | |
| 2020 | 26,522 | $1.39M | |
| 2021 | 45,636 | $1.80M | |
| 2022 | 41,671 | $1.83M | |
| 2023 | 74,663 | $1.94M | |
| 2024incomplete | 80,517 | $1.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 54% | 67,692 | 54,495 | $5.69M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 39,340 | 33,537 | $2.33M |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 5.7% | 7,047 | 6,976 | $604K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 5.2% | 5,798 | 5,730 | $549K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.2% | 3,076 | 3,042 | $231K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.4% | 1,557 | 1,456 | $150K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.2% | 1,073 | 1,002 | $123K |
| 99385 | <1% | 1,018 | 1,003 | $100K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 740 | 734 | $74K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 926 | 897 | $62K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 592 | 588 | $50K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,384 | 1,782 | $45K |
106 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,602 | $45K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,361 | $41K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 876 | $34K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 738 | $32K |
| 93976 | <1% | 328 | $31K | |
| 99386 | <1% | 177 | $21K | |
| 99457 | <1% | 923 | $20K | |
| 96127 | <1% | 6,387 | $19K | |
| 99490 | Ccm add 20min | <1% | 1,452 | $18K |
| 99458 | <1% | 516 | $17K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 341 | $17K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,609 | $16K |
| 99454 | <1% | 633 | $16K | |
| 90688 | <1% | 888 | $15K | |
| 93000 | <1% | 1,476 | $13K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 534 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 265 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 796 | $10K |
| 90756 | <1% | 443 | $9K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 602 | $8K |
| 81002 | <1% | 3,240 | $8K | |
| 99401 | <1% | 429 | $7K | |
| 99442 | <1% | 173 | $7K | |
| 81025 | <1% | 943 | $6K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 135 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,846 | $5K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 243 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 247 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 641 | $4K |
| 90674 | <1% | 171 | $4K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 42 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 249 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,800 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 40 | $2K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 96 | $2K |
| 20610 | <1% | 79 | $2K | |
| 76770 | <1% | 38 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,473 | $2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 242 | $2K |
| 90661 | <1% | 66 | $2K | |
| 83014 | <1% | 345 | $2K | |
| 99496 | <1% | 12 | $2K | |
| 20552 | <1% | 89 | $1K | |
| 99441 | <1% | 76 | $1K | |
| 92229 | <1% | 61 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 70 | $1K |
| 73630 | <1% | 50 | $1K | |
| 0001A | <1% | 30 | $990.08 | |
| 99051 | <1% | 287 | $824.76 | |
| 72100 | <1% | 39 | $797.80 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 566 | $704.89 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $696.26 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 78 | $432.47 |
| G0008 | Administration of influenza virus vaccine | <1% | 82 | $395.76 |
| 90658 | <1% | 15 | $303.67 | |
| 86580 | <1% | 60 | $298.27 | |
| 99406 | <1% | 30 | $203.57 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 17 | $140.20 |
| 82947 | <1% | 45 | $122.59 | |
| 69209 | <1% | 13 | $103.76 | |
| 99000 | <1% | 79 | $103.04 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 96 | $88.92 |
| 99050 | <1% | 16 | $30.00 | |
| 96160 | <1% | 14 | $22.12 | |
| 3074F | <1% | 17,124 | $17.51 | |
| 3078F | <1% | 14,389 | $14.63 | |
| 3008F | <1% | 24,863 | $10.35 | |
| 3079F | <1% | 6,921 | $6.64 | |
| 1034F | <1% | 3,587 | $4.05 | |
| 3075F | <1% | 3,448 | $3.12 | |
| 3077F | <1% | 3,313 | $2.68 | |
| 3080F | <1% | 2,561 | $2.00 | |
| 1035F | <1% | 501 | $0.75 | |
| 1159F | <1% | 13,234 | $0.29 | |
| 1160F | <1% | 16,610 | $0.29 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 341 | $0.01 |
| 1036F | <1% | 25,141 | $0.01 | |
| 3725F | <1% | 5,145 | $0.01 | |
| 1000F | 0% | 197 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 1,082 | $0.00 |
| 3044F | 0% | 982 | $0.00 | |
| 1126F | 0% | 197 | $0.00 | |
| 3048F | 0% | 385 | $0.00 | |
| 2000F | 0% | 2,441 | $0.00 | |
| 4037F | 0% | 64 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 17 | $0.00 |
| 3049F | 0% | 172 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 166 | $0.00 |
| 1125F | 0% | 30 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 35 | $0.00 |
| 1101F | 0% | 27 | $0.00 | |
| 3061F | 0% | 14 | $0.00 | |
| 4000F | 0% | 32 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 14 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 164 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 104 | $0.00 |
| 2014F | 0% | 48 | $0.00 | |
| 3050F | 0% | 105 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 54 | $0.00 |
| 91300 | 0% | 12 | $0.00 | |
| 2028F | 0% | 29 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 126 | $0.00 |
| 2022F | 0% | 14 | $0.00 | |
| 3288F | 0% | 22 | $0.00 | |
| 3016F | 0% | 73 | $0.00 | |
| 99173 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSULIMAN, NABIL (MD)
| Provider | Location | Paid |
|---|---|---|
| Professional Medical Group MD PC | Livonia, MI | $589K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.